Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai NewMed Medical is an innovative Chinese medical device company specializing in the development of interventional artificial heart valves and related systems. Its lead product, Prizvalve®, is undergoing confirmatory clinical trials and has been recognized as an "innovative medical device" by the NMPA for special review. The company also develops mitral repair systems and left ventricular assist devices, with several ongoing multicenter randomized controlled studies. One of its products is expected to become the first domestically approved mitral valve replacement in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai NewMed Medical.